96 related articles for article (PubMed ID: 20223660)
1. Synthesis and biological evaluations of novel bendazac lysine analogues as potent anticataract agents.
Shen H; Gou S; Shen J; Zhu Y; Zhang Y; Chen X
Bioorg Med Chem Lett; 2010 Apr; 20(7):2115-8. PubMed ID: 20223660
[TBL] [Abstract][Full Text] [Related]
2. Radical scavenger activity of bendazac, an anticataract non-steroidal anti-inflammatory agent.
Guglielmotti A; Capezzone De Joannon A; Cazzolla N; Marchetti M; Soldo L; Cavallo G; Pinza M
Pharmacol Res; 1995 Dec; 32(6):369-73. PubMed ID: 8736488
[TBL] [Abstract][Full Text] [Related]
3. Basic data supporting the use of the l-lysine salt of bendazac in cataract.
Silvestrini B; Catanese B; Barillari G; Iorio E; Valeri P
Int J Tissue React; 1983; 5(2):217-25. PubMed ID: 6618787
[TBL] [Abstract][Full Text] [Related]
4. Effects of bendazac L-lysine salt on some metabolic enzymes of glutathione in the rabbit lens after X-irradiation.
Bono A; Militello A; Bongiorno A; Livrea MA; Pandolfo L
Ital J Biochem; 1987; 36(3):153-65. PubMed ID: 3610598
[TBL] [Abstract][Full Text] [Related]
5. Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts.
Balfour JA; Clissold SP
Drugs; 1990 Apr; 39(4):575-96. PubMed ID: 2190795
[TBL] [Abstract][Full Text] [Related]
6. Bendazac decreases in vitro glycation of human lens crystallins. Decrease of in vitro protein glycation by bendazac.
Marques C; Ramalho JS; Pereira P; Mota MC
Doc Ophthalmol; 1995; 90(4):395-404. PubMed ID: 8620822
[TBL] [Abstract][Full Text] [Related]
7. Bendazac and benzydamine for treatment of cataract: individualized therapy by the "BLOA test".
Testa M; Iuliano G; Marino E; Buongiovanni C; Paolercio F; Trapanese A; Mortow P
J Ocul Pharmacol; 1986; 2(3):251-66. PubMed ID: 3503111
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease.
Babizhayev MA
Cell Biochem Funct; 2011 Apr; 29(3):183-206. PubMed ID: 21381059
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant characteristics of some potential anticataract agents. Studies of aspirin, paracetamol, and bendazac provide support for an oxidative component of cataract.
Woollard AC; Wolff SP; Bascal ZA
Free Radic Biol Med; 1990; 9(4):299-305. PubMed ID: 2283086
[TBL] [Abstract][Full Text] [Related]
10. Photosensitized haemolysis of human erythrocytes is reduced by bendazac.
Ciancarelli-Tozzi MG; Silvestrini B; Finazzi-Agro A
Drugs Exp Clin Res; 1989; 15(5):219-22. PubMed ID: 2791873
[TBL] [Abstract][Full Text] [Related]
11. Bendazac lysine inhibition of human lens epithelial cell adhesion to polymethylmethacrylate intraocular lenses.
Soldo L; Ruggieri A; Milanese C; Pinza M; Guglielmotti A
Ophthalmic Res; 2004; 36(3):145-50. PubMed ID: 15103205
[TBL] [Abstract][Full Text] [Related]
12. Effect of bendazac lysine on lens and retina in diabetics.
Benitez del Castillo JM; Jimenez-Alfaro I; Ortega P; Castillo A; Diaz D; Toledano N; Garcia-Sanchez J
Doc Ophthalmol; 1994; 86(4):387-93. PubMed ID: 7835176
[TBL] [Abstract][Full Text] [Related]
13. Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens.
Abdelkader H; Alany RG; Pierscionek B
J Pharm Pharmacol; 2015 Apr; 67(4):537-50. PubMed ID: 25643848
[TBL] [Abstract][Full Text] [Related]
14. Investigation into the Emerging Role of the Basic Amino Acid L-Lysine in Enhancing Solubility and Permeability of BCS Class II and BCS Class IV Drugs.
Abdelkader H; Fathalla Z
Pharm Res; 2018 Jun; 35(8):160. PubMed ID: 29916057
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic characterization of bendazac and benzydamine: possible photochemical modes of action.
Jez JM; Vanderkooi JM; Laties AM
Biochem Biophys Res Commun; 1996 Apr; 221(2):266-70. PubMed ID: 8619844
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with bendazac attenuates retinal damage induced by intense light in rats.
Scorza Barcellona P; Campana A; Caranti S; D'Onofrio E; Silvestrini B
Pharmacol Res; 1991 Jul; 24(1):105-12. PubMed ID: 1946139
[TBL] [Abstract][Full Text] [Related]
17. Effects of bendazac L-lysine salt on X-ray-induced cataract in the rabbit lens.
Pandolfo L; Livrea MA; Bono A
Exp Eye Res; 1986 Feb; 42(2):167-75. PubMed ID: 3699106
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and biological evaluation of novel 4'-fluoro-2'-hydroxy-chalcone derivatives as antioxidant, anti-inflammatory and analgesic agents.
Abdellatif KR; Elshemy HA; Salama SA; Omar HA
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):484-91. PubMed ID: 25198887
[TBL] [Abstract][Full Text] [Related]
19. Anti-cataractogenic effect of curcumin and aminoguanidine against selenium-induced oxidative stress in the eye lens of Wistar rat pups: An in vitro study using isolated lens.
Manikandan R; Thiagarajan R; Beulaja S; Chindhu S; Mariammal K; Sudhandiran G; Arumugam M
Chem Biol Interact; 2009 Oct; 181(2):202-9. PubMed ID: 19481068
[TBL] [Abstract][Full Text] [Related]
20. Trigonella foenum-graecum (Fenugreek) protects against selenite-induced oxidative stress in experimental cataractogenesis.
Gupta SK; Kalaiselvan V; Srivastava S; Saxena R; Agrawal SS
Biol Trace Elem Res; 2010 Sep; 136(3):258-68. PubMed ID: 19823776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
